HIGHLIGHTS
- who: Amandine Bernard and colleagues from the University of Limoges, Limoges, France have published the research: Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice, in the Journal: Pharmaceutics 2022, 14, 2823. of /2022/
- what: The authors thus sought to elucidate the contribution of CCK2R to VCR-induced pain and to examine if the inhibition of CCK2R may be a potentially effective strategy to prevent the development of VCR-induced neuropathic pain. The authors aimed to investigate the potential changes in pathways following VCR exposure. The neuroprotective effects obtained . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.